THERMAZENE Drug Patent Profile
✉ Email this page to a colleague
When do Thermazene patents expire, and when can generic versions of Thermazene launch?
Thermazene is a drug marketed by Thepharmanetwork Llc and is included in one NDA.
The generic ingredient in THERMAZENE is silver sulfadiazine. There are twenty-two drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the silver sulfadiazine profile page.
Summary for THERMAZENE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 10 |
Raw Ingredient (Bulk) Api Vendors: | 71 |
Clinical Trials: | 1 |
Patent Applications: | 7,231 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in THERMAZENE? | THERMAZENE excipients list |
DailyMed Link: | THERMAZENE at DailyMed |
Recent Clinical Trials for THERMAZENE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Oregon Health and Science University | N/A |
OHSU Knight Cancer Institute | N/A |
Pharmacology for THERMAZENE
Drug Class | Sulfonamide Antibacterial |
Anatomical Therapeutic Chemical (ATC) Classes for THERMAZENE
US Patents and Regulatory Information for THERMAZENE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Thepharmanetwork Llc | THERMAZENE | silver sulfadiazine | CREAM;TOPICAL | 018810-001 | Dec 23, 1985 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |